Skip to content
healthcare.dev

Dacarbazine

NDC 71288-174, Dacarbazine, injection, powder, for solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-174
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075259
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DACARBAZINE200 mg/20mL

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
71288-174-217128801742110 VIAL, SINGLE-USE in 1 CARTON (71288-174-21) / 20 mL in 1 VIAL, SINGLE-USE (71288-174-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64037f45-6245-49f0-9ae8-18d75753ae1f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71288-174

Use it

Look up 71288-174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.